StonvexLoading…
StonvexCore line items from ITRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $577.40M | $586.98M | $2.37B | $1.80B | $1.21B |
Operating Income | Not available | $67.58M | $313.07M | $234.41M | $152.63M |
Net Income | Not available | $53.46M | $301.06M | $199.43M | $133.81M |
EPS (Diluted) | $1.31 | $1.18 | $6.50 | $4.30 | $2.89 |
Total Assets | Not available | $3.98B | $3.72B | $3.71B | $3.62B |
Total Liabilities | Not available | $2.35B | $1.98B | $2.00B | $1.99B |
Cash & Equivalents | Not available | $712.85M | $1.02B | $1.33B | $1.22B |
Free Cash Flow OCF − CapEx | Not available | $78.97M | $383.06M | $271.55M | $158.15M |
Shares Outstanding | Not available | 44.32M | 44.93M | 45.79M | 45.71M |